Literature DB >> 17504801

Recurrent tuberculosis from 1992 to 2004 in a metropolitan area.

J Cacho1, A Pérez Meixeira, I Cano, T Soria, A Ramos Martos, M Sánchez Concheiro, S Samper, P Gavin, C Martín.   

Abstract

The proportion of recurrent tuberculosis (TB) cases caused by re-infection has varied widely in previous studies. The aim of the present study was to determine the relative frequency of relapse and exogenous re-infection in patients with second episodes of TB, using DNA fingerprinting. A population-based retrospective longitudinal descriptive study was conducted in Madrid (Spain) during 1992-2004. The study consisted of 645 patients with culture-confirmed TB. Of these, 20 (3.1%) were retained because they presented with a second isolate of Mycobacterium tuberculosis. Finally, 12 of these cases were excluded because they did not complete the full treatment prescribed. All strains were typed by restriction fragment length polymorphism analysis and some by mycobacterial interspersed repetitive unit-variable number of tandem repeats analysis. The patients with recurrent TB were compared with those without recurrent TB. For seven out of the eight patients, the restriction fragment length polymorphism patterns of the Mycobacterium tuberculosis strains from the episodes of recurrent disease showed identical initial and final genotypes, indicating relapse; the remaining recurrent case showed different genotypes, suggesting exogenous re-infection. Re-infection is possible among people in developed countries, but the rates are lower than those occurring in high-risk areas. The risk factors for recurrent tuberculosis should be taken into account in the follow-up of treatment and tuberculosis control strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17504801     DOI: 10.1183/09031936.00005107

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

1.  A nested case-control study on relapse predictors among tuberculosis patients treated in Yemen's NTCP.

Authors:  M S Anaam; M I M Ibrahim; A W Al Serouri; A Bassili; A Aldobhani
Journal:  Public Health Action       Date:  2012-12-21

2.  Factors associated with recurrent tuberculosis more than 12 months after treatment completion.

Authors:  L Kim; P K Moonan; C M Heilig; R S Yelk Woodruff; J S Kammerer; M B Haddad
Journal:  Int J Tuberc Lung Dis       Date:  2016-01       Impact factor: 2.373

3.  Exogenous Reinfection as a Cause of Late Recurrent Tuberculosis in the United States.

Authors:  Julia D Interrante; Maryam B Haddad; Lindsay Kim; Neel R Gandhi
Journal:  Ann Am Thorac Soc       Date:  2015-11

4.  Three-year population-based evaluation of standardized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing of Mycobacterium tuberculosis.

Authors:  Caroline Allix-Béguec; Maryse Fauville-Dufaux; Philip Supply
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

5.  Tuberculosis recurrence in a priority city in the state of São Paulo, Brazil.

Authors:  Amadeu Antonio Vieira; Danila Torres Leite; Solange Adreoni
Journal:  J Bras Pneumol       Date:  2017 Mar-Apr       Impact factor: 2.624

6.  Recurrence of tuberculosis in a low-incidence setting: a retrospective cross-sectional study augmented by whole genome sequencing.

Authors:  Laila Parvaresh; Taryn Crighton; Elena Martinez; Andrea Bustamante; Sharon Chen; Vitali Sintchenko
Journal:  BMC Infect Dis       Date:  2018-06-07       Impact factor: 3.090

7.  Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse?

Authors:  Juan-Pablo Millet; Evelyn Shaw; Angels Orcau; Martí Casals; Jose M Miró; Joan A Caylà
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

8.  Factors associated with diagnostic delay in recurrent TB.

Authors:  Zhongyao Xie; Tingwei Wang; Hongguang Chen; Donglin Wang; Xiangqi Gao; Yi Hui
Journal:  BMC Public Health       Date:  2020-08-08       Impact factor: 3.295

9.  Prospective 1-year follow-up study of all cured, new sputum smear positive tuberculosis patients under the Revised National Tuberculosis Control Program in Hyderabad, Telangana State, India.

Authors:  Neeta Mathur; Chakrapani Chatla; Saba Syed; Yogesh Patel; Snigdha Pattnaik; Dilip Mathai; Adepu Rajesham
Journal:  Lung India       Date:  2019 Nov-Dec

10.  Recurrent tuberculosis in the Netherlands - a 24-year follow-up study, 1993 to 2016.

Authors:  Connie Erkens; Betül Tekeli; Dick van Soolingen; Henrieke Schimmel; Suzanne Verver
Journal:  Euro Surveill       Date:  2022-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.